Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 6/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.53 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | RGS12 | O14924 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12512912 | 1.00 | SLC6A2 (0.61) | SLC6A2SLC6A3SLC6A4LMNAHKDC1 | |
| SCHEMBL6939841 | 0.84 | LMNA (0.60) | SLC6A2SLC6A3SLC6A4LMNAAOC3 | |
| SCHEMBL18087746 | 0.84 | LMNA (0.60) | SLC6A2SLC6A3SLC6A4LMNAAOC3 | |
| SCHEMBL4071581 | 0.83 | HKDC1 (0.65) | SLC6A2SLC6A3SLC6A4LMNAHKDC1 | |
| SCHEMBL873376 | 0.82 | LMNA (0.58) | SLC6A2SLC6A3SLC6A4LMNAHKDC1 | |
| SCHEMBL18901666 | 0.82 | LMNA (0.58) | SLC6A2SLC6A3SLC6A4LMNAHKDC1 | |
| SCHEMBL10794618 | 0.82 | LMNA (0.58) | SLC6A2SLC6A3SLC6A4LMNAHKDC1 | |
| SCHEMBL1292631 | 0.82 | LMNA (0.58) | SLC6A2SLC6A3SLC6A4LMNAHKDC1 | |
| SCHEMBL17892871 | 0.82 | LMNA (0.58) | SLC6A2SLC6A3SLC6A4LMNAHKDC1 | |
| SCHEMBL4107117 | 0.82 | LMNA (0.58) | SLC6A2SLC6A3SLC6A4LMNAHKDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | claimed |
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-8309552-B2 | Immunomodulating heterocyclic compounds | MEDIGENE AG (DE) | 2012-11-13 | — | — | US | disclosed |
| US-20090312334-A1 | Immunomodulating Heterocyclic Compounds | MEDIGENE LIMITED (GB) | 2009-12-17 | — | — | US | disclosed |
| EP-0247381-B1 | 5-FLUROROURACIL DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-08-04 | — | — | EP | disclosed |
| US-5047521-A | Anticarcinogenic agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-09-10 | — | — | US | disclosed |
| EP-0247381-A2 | 5-flurorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312334-A1 | Immunomodulating Heterocyclic Compounds | CD40, CD40LG, NGFR | SLC6A2 2376/4885SLC6A3 2484/4885SLC6A4 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.